CompletedPhase 4ACTRN12611000638932
Impact of pre-operative misoprostol on blood loss during and after elective cesarean delivery.
Sponsor
Mervat Sheikh Elarab Elsedeek Omran
Enrollment
400 participants
Start Date
Jan 1, 2008
Study Type
Interventional
Conditions
Summary
The primary purpose of this study was to evaluate the efficacy of rectal misoprostol in reducing blood loss during and after cesarean delivery.
Eligibility
Sex: Females
Inclusion Criteria1
- elective cesarean, full-term pregnancy, normal blood indices, non-compromised average weight fetus.
Exclusion Criteria1
- labour pains, multiple pregnancy, bleeding disorder or thrombophilia, abnormal placenta(previa or accreta by ultrasound, fetal distress, preterm fetus.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
preoperative adminstration of 400 microgram rectal misoprostol immediately before skin incision.
preoperative adminstration of 400 microgram rectal misoprostol immediately before skin incision.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000638932